ASP2215

Known as: ASP-2215 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2015-2018
0120152018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Acute myeloid leukemia (AML) is a heterogeneous disease with cure rates of only 30-40% in patients <60 years old. Cytogenetic and… (More)
Is this relevant?
2016
2016
UNLABELLED For acute myeloid leukemia (AML), identification of activating mutations in the FMS-like tyrosine kinase-3 (FLT3) has… (More)
  • figure 1
  • table 1
Is this relevant?
Review
2016
Review
2016
FLT3 (Fms-like tyrosine kinase 3) inhibitors are tyrosine kinase inhibitors. The first-generation FLT3 inhibitors were developed… (More)
Is this relevant?
2015
2015
Claire Thom speaks to Gemma Westcott, Commissioning Editor: Claire Thom joined Astellas in 2013 as the Therapeutic Area Head for… (More)
Is this relevant?